(Q83164257)
Statements
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women (English)
T Cigler
H Richardson
M J Yaffe
C J Fabian
D Johnston
E Nassif
M E Wood
J L Pater
H Hu
S Qi
D Tu